After Hours
$
89.51
Change
-0.22 -0.25%
Volume
Volume 90,095
Aug 10, 2022, 7:44 p.m.
Quotes are delayed by 20 min
Previous close
$ 85.12
$ 89.73
Change
+4.61 +5.42%
Day low
Day high
$87.58
$90.10

52 week low
52 week high
$66.89
$164.86

Market cap
$33.42B
Average volume
3.23M
P/E ratio
185.24
Rev. per Employee
$424,349
EPS
0.48
Dividend
N/A
Div yield
N/A
Ex dividend date
N/A
MarketWatch News on DXCM
-
DexCom Inc. stock outperforms competitors on strong trading day
- MarketWatch Automation
-
DexCom Inc. stock underperforms Tuesday when compared to competitors
- MarketWatch Automation
-
DexCom Inc. stock rises Monday, outperforms market
- MarketWatch Automation
-
DexCom Inc. stock underperforms Friday when compared to competitors
- MarketWatch Automation
-
DexCom Inc. stock outperforms competitors despite losses on the day
- MarketWatch Automation
-
DexCom Inc. stock outperforms competitors on strong trading day
- MarketWatch Automation
-
DexCom Inc. stock outperforms market on strong trading day
- MarketWatch Automation
-
DexCom Inc. stock outperforms market on strong trading day
- MarketWatch Automation
-
DexCom Inc. stock underperforms Friday when compared to competitors
- MarketWatch Automation
-
DexCom Shares Are Falling, but Analysts Still See a Winner
- Barron's Online
-
Amazon, Apple, Roku, Intel and More Stock Market Movers
- Barron's Online
-
DexCom stock drops 17% after company's Q2 miss
- Claudia Assis
-
DexCom Inc. stock outperforms market on strong trading day
- MarketWatch Automation
-
DexCom Inc. stock rises Wednesday, outperforms market
- MarketWatch Automation
-
DexCom Inc. stock underperforms Tuesday when compared to competitors despite daily gains
- MarketWatch Automation
-
DexCom Inc. stock falls Monday, underperforms market
- MarketWatch Automation
-
DexCom Inc. stock outperforms market despite losses on the day
- MarketWatch Automation
-
DexCom Inc. stock rises Thursday, outperforms market
- MarketWatch Automation
-
DexCom Inc. stock outperforms market on strong trading day
- MarketWatch Automation
- Loading more headlines...
Analyst Ratings
-
Analysts’ Views on Tandem Diabetes Care after Its FDA Approval
- MarketRealist.com
-
Benzinga's Top Analyst Calls From March 29, 2018
- Benzinga.com
-
How Wall Street Reacted to the FDA Approval of Abbott’s Freestyle Libre
- MarketRealist.com
Other News on DXCM
-
Tracking Baillie Gifford's 13F Portfolio - Q2 2022 Update
- Seeking Alpha
-
2 Growth Stocks That Just Hit Setbacks: Are They Buys?
- Motley Fool
-
Why DexCom Stock Is Falling Today
- Motley Fool
-
DexCom (DXCM) Q2 2022 Earnings Call Transcript
- Motley Fool
-
DexCom, Inc. 2022 Q2 - Results - Earnings Call Presentation
- Seeking Alpha
-
DexCom (DXCM) Matches Q2 Earnings Estimates
- Zacks.com
-
- Edgar Online - (EDG = 10Q, 10K)
-
- Motley Fool
-
Notable earnings after Thursday's close
- Seeking Alpha
-
DexCom Q2 2022 Earnings Preview
- Seeking Alpha
-
Insider Alert: An Insider Just Sold DexCom Inc Shares
- GuruFocus.com
- Loading more headlines...
Earnings Announcement
Press Releases on DXCM
-
Dexcom Announces Upcoming Conference Presentation
- BusinessWire - BZX
-
- MarketNewsVideo.com
-
Remote Patient Monitoring Market Report 2022, Size, Share, Trends and Forecast to 2027
- SUPER MARKET RESEARCH
-
- MarketNewsVideo.com
-
- MarketNewsVideo.com
-
Dexcom Reports Second Quarter 2022 Financial Results
- BusinessWire - BZX
-
Dexcom G6 Continuous Glucose Monitoring System Mobile App Now Available in Spanish
- BusinessWire - BZX
-
Medical Wearables Development Reaches Fever Pitch
- PR Newswire - PRF
-
Dexcom Canada Achieves Great Place to Work® Certification
- BusinessWire - BZX
-
- MarketNewsVideo.com
-
- MarketNewsVideo.com
-
- MarketNewsVideo.com
-
- MarketNewsVideo.com
-
Dexcom Issues Statement on Recent Market Speculation
- BusinessWire - BZX
-
This Top Growth Is Oversold and Could Be a Steal of a Deal
- Baystreet.ca
- Loading more headlines...
Rates »
National averages from Bankrate.com
National averages from Bankrate.com
National averages from Bankrate.com